Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
De’Angelo Hermesky
Observed names:
D. Hermesky,
De'angelo Hermesky,
Deangelo Hermesky
Institution:
The University of Texas Health Science Center at Houston
Observed institutions:
The University of Texas MD Anderson Cancer Center,
Stanford Medicine,
The University of Texas Health Science Center at Houston,
Stanford University
ORCID:
0009-0006-2697-1261
Observed ORCID:
0009-0006-2697-1261
OpenAlex ID:
A5092763701
Robust nuclease-dead S. aureus dCas9-mediated alpha-synuclein knockdown in substantia nigra in a humanized mouse model of Parkinson’s disease
2023
·
C. Alejandra Morato Torres
, Faria Zafar
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
5
PDF
Automated Health Care Thematic Analysis Using a Multiagent Large Language Model: Algorithm Development and Evaluation Study
2026
·
Qidi Xu
, Nuzha Amjad
, et al.
·
Journal of Medical Internet Research
The Evolving Role of Advanced Practice Providers in Spine Care: A National Analysis of Utilization, Reimbursement, and Access
2026
·
De’Angelo Hermesky
, Ashley Knebel
, et al.
·
Spine
927 Enhanced survival with immune checkpoint inhibitors across tumor histologies during the COVID-19 pandemic is strongly associated with SARS-COV-2 mRNA vaccination
2025
·
Sage Copling
, Adam J Grippin
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
1526P Unexpected improvements in survival among patients treated with immune checkpoint inhibitors during the COVID-19 pandemic are strongly associated with SARS-CoV-2 mRNA vaccination
2025
·
A. Grippin
, S. Copling
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
5
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type